ID   Sp2/mIL-6 (hTERT)
AC   CVCL_F1LF
SY   Sp2/mIL-6 MPT
RX   PubMed=15345310;
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=15345310; DOI=10.1016/j.jim.2004.05.005;
RA   Dessain, Scott K.
RA   Adekar, Sharad P.
RA   Stevens, Jennifer B.
RA   Carpenter, Katherine A.
RA   Skorski, Maria Leilani
RA   Barnoski, Barry L.
RA   Goldsby, Richard A.
RA   Weinberg, Robert Allan
RT   "High efficiency creation of human monoclonal antibody-producing
RT   hybridomas.";
RL   J. Immunol. Methods 291:109-122(2004).
//
RX   PubMed=18514220; DOI=10.1016/j.jim.2008.04.008; PMCID=PMC2519117;
RA   Yu, Xiao-Cong
RA   McGraw, Patricia A.
RA   Smith-House, Frances
RA   Crowe, James Earl Jr.
RT   "An optimized electrofusion-based protocol for generating
RT   virus-specific human monoclonal antibodies.";
RL   J. Immunol. Methods 336:142-151(2008).
//